Fenfluramine for treating seizures associated with Dravet syndrome: Appraisal consultation document

DRAFT guidance does not recommend use as an add-on to other antiepileptic medicines for treating seizures associated with Dravet syndrome in people aged 2 years and older because it was not possible to estimate cost effectiveness to make a decision based on uncertainties in data.

National Institute for Health and Care Excellence